IL124568A0 - Pharmaceutical compositions comprising flurbiprofen - Google Patents

Pharmaceutical compositions comprising flurbiprofen

Info

Publication number
IL124568A0
IL124568A0 IL12456896A IL12456896A IL124568A0 IL 124568 A0 IL124568 A0 IL 124568A0 IL 12456896 A IL12456896 A IL 12456896A IL 12456896 A IL12456896 A IL 12456896A IL 124568 A0 IL124568 A0 IL 124568A0
Authority
IL
Israel
Prior art keywords
flurbiprofen
pharmaceutical compositions
sugar
treatment
relates
Prior art date
Application number
IL12456896A
Other languages
English (en)
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of IL124568A0 publication Critical patent/IL124568A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
IL12456896A 1995-11-22 1996-11-21 Pharmaceutical compositions comprising flurbiprofen IL124568A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9523833.3A GB9523833D0 (en) 1995-11-22 1995-11-22 Medical treatment
PCT/EP1996/005208 WO1997018802A1 (en) 1995-11-22 1996-11-21 Pharmaceutical compositions comprising flurbiprofen

Publications (1)

Publication Number Publication Date
IL124568A0 true IL124568A0 (en) 1998-12-06

Family

ID=10784245

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12456896A IL124568A0 (en) 1995-11-22 1996-11-21 Pharmaceutical compositions comprising flurbiprofen

Country Status (21)

Country Link
US (2) US5889057A (ru)
EP (1) EP0862424B1 (ru)
CN (1) CN1148177C (ru)
AT (1) ATE252382T1 (ru)
AU (1) AU707749B2 (ru)
BG (1) BG64166B1 (ru)
CA (1) CA2238271C (ru)
CZ (1) CZ289643B6 (ru)
DE (1) DE69630460T2 (ru)
DK (1) DK0862424T3 (ru)
ES (1) ES2208768T3 (ru)
GB (1) GB9523833D0 (ru)
HU (1) HU225235B1 (ru)
IL (1) IL124568A0 (ru)
NO (1) NO317287B1 (ru)
NZ (1) NZ322933A (ru)
PT (1) PT862424E (ru)
RU (1) RU2203655C2 (ru)
SK (1) SK284092B6 (ru)
UA (1) UA46807C2 (ru)
WO (1) WO1997018802A1 (ru)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
GB9710521D0 (en) * 1997-05-22 1997-07-16 Boots Co Plc Process
AU7916798A (en) * 1997-05-22 1998-12-11 Boots Company Plc, The Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat
WO1998052540A1 (en) * 1997-05-22 1998-11-26 The Boots Company Plc Pharmaceutical compositions
JP4698843B2 (ja) * 1999-05-17 2011-06-08 エーザイ インコーポレイテッド 生体活性剤の改良された細胞取り込み
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
RU2004114552A (ru) * 2001-11-13 2005-02-20 Фармация Корпорейшн (Us) Пероральная дозированная форма сульфонамидного пролекарства
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
WO2004012662A2 (en) * 2002-08-01 2004-02-12 Aesgen, Inc. Improved treatment of cancer with glutamine
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS
US20040265359A1 (en) * 2003-04-17 2004-12-30 Sacks Gordon S. Oral delivery formulations of L-glutamine
AU2004311577A1 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
WO2005108683A1 (en) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020853A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
GB2423710A (en) 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
BRPI0613611A2 (pt) * 2005-07-22 2011-01-18 Myriad Genetics Inc formulações de alta concentração de fármaco e formas de dosagens
WO2007055887A1 (en) * 2005-11-02 2007-05-18 Teikoku Pharma Usa, Inc. Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
US7282224B1 (en) * 2006-06-09 2007-10-16 Guthy-Renker Corporation Pain relief composition
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
US7754234B2 (en) * 2006-07-12 2010-07-13 Jones Thomas L Composition and method of treating a sore throat
US20080107747A1 (en) * 2006-10-23 2008-05-08 Roederer Joy E Pain relief composition
EA200901188A1 (ru) * 2007-07-23 2010-04-30 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Органолептически приемлемые дозированные лекарственные формы индольных агонистов серотониновых рецепторов для перорального применения и способы их применения
LT2432454T (lt) 2009-05-19 2017-07-10 Neuroderm Ltd Kompozicijos, skirtos nepertraukiamam dopa dekarboksilazės inhibitorių vartojimui
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
NZ610911A (en) * 2010-11-15 2015-02-27 Neuroderm Ltd Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same
GB201021267D0 (en) * 2010-12-15 2011-01-26 Reckitt Benckiser Healthcare Int Ltd Novel pharmaceutical formulation
MX2014014902A (es) 2012-06-05 2015-03-04 Neuroderm Ltd Composiciones que comprenden apomorfina y acidos organicos y usos de las mismas.
GB201216893D0 (en) 2012-09-21 2012-11-07 Aesica Pharmaceuticals Ltd Drug substance preparations, pharmaceutical compositions and dosage forms comprising s-(+)-flurbiprofen
HRP20231716T1 (hr) 2014-03-13 2024-03-15 Neuroderm Ltd. Pripravci inhibitora dopa dekarboksilaze
US10258585B2 (en) 2014-03-13 2019-04-16 Neuroderm, Ltd. DOPA decarboxylase inhibitor compositions
CN110812331A (zh) * 2018-08-10 2020-02-21 北京普德康利医药科技发展有限公司 一种氟比洛芬咽部滞留颗粒
US11213502B1 (en) 2020-11-17 2022-01-04 Neuroderm, Ltd. Method for treatment of parkinson's disease
US11844754B2 (en) 2020-11-17 2023-12-19 Neuroderm, Ltd. Methods for treatment of Parkinson's disease
US11331293B1 (en) 2020-11-17 2022-05-17 Neuroderm, Ltd. Method for treatment of Parkinson's disease
CN115536525B (zh) * 2022-09-23 2024-02-23 南京知和医药科技有限公司 一种s-（+）-氟比洛芬盐及其制备方法、药物组合物和用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1062721A (en) * 1975-12-15 1979-09-18 Anthony A. Sinkula Propionic acid derivatives
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
JPH0647532B2 (ja) * 1983-08-31 1994-06-22 ジ アツプジヨン カンパニ− 歯槽骨吸収の治療
ZA869433B (en) * 1985-12-16 1988-07-27 Cilag Ag Non-irritating suprofen solution
AU8320387A (en) * 1986-10-22 1988-05-25 Upjohn Company, The Treatment of gingivitis with ibuprofen or flurbiprofen
JPS63156715A (ja) * 1986-12-19 1988-06-29 Teisan Seiyaku Kk 即効性の徐放化製剤
JP2540581B2 (ja) * 1988-02-04 1996-10-02 三省製薬株式会社 外用剤
US4931473A (en) * 1989-02-15 1990-06-05 Richardson-Vicks Inc. Anesthetic oral compositions
DK0486561T4 (da) * 1989-08-17 1999-04-26 Sepracor Inc Bukkalt præparat indeholdende S(+)-ketoprofen
US5190981A (en) * 1989-08-17 1993-03-02 Sepracor Inc. Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
JP2738092B2 (ja) * 1989-11-17 1998-04-08 ライオン株式会社 口腔用組成物
JPH0426618A (ja) * 1990-05-21 1992-01-29 Japan Tobacco Inc トローチ剤
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
DE4028906A1 (de) * 1990-09-12 1992-03-19 Paz Arzneimittelentwicklung Arzneimittel sowie deren herstellung und deren verwendung bei der bekaempfung von schmerzen und/oder entzuendungen und/oder fieber an tieren und menschen
WO1994013280A1 (en) * 1992-12-04 1994-06-23 Mayor Pharmaceutical Laboratories, Inc. Sprayable analgesic composition and method of use
WO1994014476A1 (en) * 1992-12-21 1994-07-07 The Procter & Gamble Company Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
JPH10505087A (ja) * 1994-09-02 1998-05-19 バージニア カマンウェルス ユニバーシティ 非麻薬性鎮痛剤および無痛エンハンサーを含有する疼痛緩和組成物
US5567733B1 (en) * 1995-04-27 1999-08-24 Jon G Dishler Irritation relief using nonsteroidal anti-inflammatory compounds
WO1997002273A1 (en) * 1995-07-05 1997-01-23 The Procter & Gamble Company Warming compounds
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
EP0910339B1 (en) * 1996-04-12 2005-02-02 Novadel Pharma Inc. Buccal polar spray

Also Published As

Publication number Publication date
CZ289643B6 (cs) 2002-03-13
AU2611997A (en) 1997-06-11
WO1997018802A1 (en) 1997-05-29
PT862424E (pt) 2004-02-27
CA2238271C (en) 2008-08-12
DE69630460T2 (de) 2004-08-19
SK284092B6 (sk) 2004-09-08
HUP0000180A3 (en) 2001-10-29
US6166083A (en) 2000-12-26
EP0862424B1 (en) 2003-10-22
GB9523833D0 (en) 1996-01-24
RU2203655C2 (ru) 2003-05-10
UA46807C2 (uk) 2002-06-17
NO982294D0 (no) 1998-05-20
AU707749B2 (en) 1999-07-22
CN1148177C (zh) 2004-05-05
EP0862424A1 (en) 1998-09-09
US5889057A (en) 1999-03-30
ATE252382T1 (de) 2003-11-15
DE69630460D1 (de) 2003-11-27
HU225235B1 (en) 2006-08-28
CZ156598A3 (cs) 1998-08-12
ES2208768T3 (es) 2004-06-16
BG64166B1 (bg) 2004-03-31
HUP0000180A2 (hu) 2000-08-28
NO982294L (no) 1998-07-20
NO317287B1 (no) 2004-10-04
SK66598A3 (en) 1998-12-02
NZ322933A (en) 2000-02-28
BG102526A (en) 1999-02-26
CN1207677A (zh) 1999-02-10
DK0862424T3 (da) 2003-12-29
CA2238271A1 (en) 1997-05-29

Similar Documents

Publication Publication Date Title
IL124568A0 (en) Pharmaceutical compositions comprising flurbiprofen
DK1586322T3 (da) Sammensætninger indeholdende thalidomid og dextamethason til behandling af cancer
LU91145I9 (ru)
NO11062A (no) Farmasöytisk sammensetning og matvaresupplement
IL162214A0 (en) Pyridine derivatives and pharmaceutical compositions containing the same
DK0915898T3 (da) Krystalform I af clarithromycin
ZA964929B (en) Oral formulations of S(+)-ibuprofen.
FR2714594B3 (fr) Structure de diffuseur pour infusion de plantes médicinales.
IL119989A0 (en) Pharmaceutical compositions for oral treatment of multiple sclerosis
HUP0001014A2 (hu) Gasztrointesztinális lipáz inhibitorok felhasználása
NO980317L (no) Anvendelse av Calendula-glykosider for behandling av psoriasis
TR199901101T2 (xx) Gastroenstentinal hastal�klar�n tedavisine y�nelik bizmut ve nsaid i�eren bile�imler.
ATE360428T1 (de) Analgetisches arzneimittel
AU641279B2 (en) Oligosaccharide derivatives
BG104179A (en) Phanquinon administration for the treatment of the alzheimer&#39;s disease
ITMI932014A0 (it) Composizioni farmaceutiche orali effervescenti contenenti estrone
IL127143A0 (en) Phospholipid terivatives of non-steroidal anti inflammatory drugs
BG104427A (en) Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
FR2759587B1 (fr) Composition pharmaceutique pour l&#39;administration buccale de thiocolchicoside
FR2711524B1 (fr) Procédé de préparation de compositions orales contenant des quinolones.
GR1002385B (el) Καθαρη μορφη στρεπτογραμινων, παρασκευη αυτης και φαρμακευτικες συνθεσεις που την περιεχουν.
AU5768298A (en) Use of benzoylalkyl-1,2,3,6-tetrahydropyridins
DK1237552T3 (da) Kombination af lumilysergol og riluzol for forebyggelse og/eller behandling af motorisk neuron-sygdomme
IT1255678B (it) Composizioni farmaceutiche per la somministrazione di paratormone, suoi frammenti biologicamente attivi o peptidi correlati per via rettale.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees